SMI
11.488,28
PKT
+103,36
PKT
+0,91
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
15.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
15.04.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.24 | Givaudan Hold | Deutsche Bank AG | |
12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
11.04.24 | UBS Overweight | JP Morgan Chase & Co. | |
11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.04.24 | Givaudan Sell | UBS AG | |
11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
11.04.24 | Givaudan Reduce | Baader Bank | |
11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.24 | UBS Outperform | RBC Capital Markets | |
10.04.24 | Novartis Buy | UBS AG | |
09.04.24 | Roche Neutral | UBS AG | |
09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.04.24 | Roche Equal Weight | Barclays Capital | |
08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
04.04.24 | Novartis Buy | UBS AG | |
04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
04.04.24 | UBS Outperform | RBC Capital Markets | |
03.04.24 | Swiss Re Sell | UBS AG | |
03.04.24 | Givaudan Sell | UBS AG | |
03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
02.04.24 | Givaudan Underweight | Barclays Capital | |
02.04.24 | Richemont Overweight | Barclays Capital | |
02.04.24 | Richemont Buy | UBS AG | |
02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.